Trial Profile
Pharmacokinetic Pilot Study on Budesonide/Formoterol Easyhalers and Symbicort Turbuhaler; an Open, Randomised, Single Centre, Single Dose Study With Crossover Design in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Acronyms Reco-Pilot
- Sponsors Orion
- 24 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 05 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.